Clinical Trial Update: Gemcitabine Hydrochloride and Cisplatin Before Surgery in Treating Patients With Muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gemcitabine hydrochloride and cisplatin before surgery in patients with muscle invasive bladder cancer was terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine hydrochloride (Gemcitabine hydrochloride)

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Distal Urethral Cancer, Proximal Urethral Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-04-06